NeuroScientific Biopharmaceuticals Limited Share Price
Equities
NSB
AU0000012973
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.052 AUD | +8.33% | 0.00% | +18.18% |
Sales 2022 | - | Sales 2023 | 4.95M 3.26M 260M | Capitalization | 11.48M 7.55M 602M |
---|---|---|---|---|---|
Net income 2022 | -10M -6.58M -524M | Net income 2023 | -1M -658K -52.43M | EV / Sales 2022 | - |
Net cash position 2022 | 7.22M 4.75M 378M | Net cash position 2023 | 4.91M 3.23M 258M | EV / Sales 2023 | 1.33 x |
P/E ratio 2022 |
-2.47
x | P/E ratio 2023 |
-10.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.16% |
1 day | +8.33% | ||
Current month | +10.64% | ||
1 month | -5.45% | ||
3 months | +48.57% | ||
6 months | -13.33% | ||
Current year | +18.18% |
Managers | Title | Age | Since |
---|---|---|---|
Simon Scott
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/22 |
Dougal Thring
COO | Chief Operating Officer | - | 30/03/21 |
Anton Uvarov
BRD | Director/Board Member | - | 28/09/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anton Uvarov
BRD | Director/Board Member | - | 28/09/17 |
Chairman | - | 11-16 | |
Tony Keating
BRD | Director/Board Member | - | 12-04 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.052 | +8.33% | 105 739 |
26/04/24 | 0.048 | -7.69% | 377,703 |
24/04/24 | 0.052 | -1.89% | 128,144 |
23/04/24 | 0.053 | +1.92% | 188,602 |
22/04/24 | 0.052 | -1.89% | 67,124 |
Delayed Quote Australian S.E., April 29, 2024 at 05:18 am
More quotes1st Jan change | Capi. | |
---|---|---|
+18.18% | 4.53M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NSB Stock